Pharmacy & Controlled Substances — regulation & compliance changes
Retail, independent, and compounding pharmacies tracking DEA controlled-substance scheduling and quotas, state Prescription Drug Monitoring Program (PDMP) rules, and board-of-pharmacy licensing and dispensing changes — where a scheduling or PDMP misstep risks the DEA registration the business runs on.
Aforeworn watches Pharmacy & Controlled Substances around the clock so you never have to refresh a government page again. Every detected change becomes a plain-English briefing covering what changed, who it affects, what you must do, and by when. Forewarned is forearmed.
Stay ahead of every Pharmacy & Controlled Substances change
Real-time alerts, plain-English impact briefs, and a full searchable history — 41+ changes tracked in Pharmacy & Controlled Substances so far.
Monitor this regulation✓ No card charged during your trial · ✓ Cancel anytime · ✓ Every alert links to the official source
Recent changes in Pharmacy & Controlled Substances
- IL HB0004: MEDICAID-PHARMACY SERVICES
- Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661
- Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
- Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability
- Amanda Ward, N.D.; Decision and Order
- Mariana Moualem, F.N.P.; Decision and Order
- Mark Allen, D.D.S.; Decision and Order
- David Enright, M.D.; Decision and Order
- Shane Lydon, M.D.; Decision and Order
- Barlow St-Clair Lynch, M.D.; Decision and Order
- United States v. Keller
- United States v. Sargent
- People v. Sims
- United States v. Soto
- Ohio to tighten oversight of weight-loss drug copies by limiting inventory - The Columbus Dispatch
- Massachusetts Board of Pharmacy to Take a Big Step: Licensing Nonresident Pharmacies - Holland & Knight
- Proposed FDA Rule Could Limit Pharmacy Compounding - Pharmacy Times
- Gov. DeWine orders Ohio Board of Pharmacy to ban synthetic kratom immediately - The Statehouse News Bureau
- Ohio Board of Pharmacy issues emergency ruling banning most kratom products for 180 days - Ohio Capital Journal
- DEA to publish 4th extension of telehealth prescribing rule in wave of relief for virtual care providers - Fierce Healthcare
- President Trump Issues Executive Order to Remove Marijuana from Schedule I – Concerns about Broadcast Advertising Remain - Broadcast Law Blog
- California Enacts New Law Requiring California Licensure for Pharmacists-in-Charge of Nonresident Pharmacies — Effective July 1, 2026 - Buchanan Ingersoll & Rooney PC
- Pharmacy reimbursement law goes into effect Wednesday - Alabama Daily News
- DEA extends telemedicine flexibilities for controlled substance prescribing for 2026 - JD Supra
- DEA Releases Fourth Temporary Extension of Telemedicine Flexibilities - RCPA | PA
- California Expands Oversight of Non-Resident Pharmacies With New PIC Licensure and Compliance Requirements - Hinshaw & Culbertson LLP
- Texas Telehealth Pharmacy Rule Signals a New Compliance Era: What Every Pharmacy Should Know About the Board’s Proposed Informed Consent Requirements - Buchanan Ingersoll & Rooney PC
- Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
- Designation of P2P Methyl Glycidic Acid as a List I Chemical
- Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
- Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
- Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
- Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
- Revision of Applications for Manufacturing and Procurement Quotas
- Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
- Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
- Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
- Designation of Phenethyl Halides as List I Chemicals
- Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
- Frederick Tanzer, M.D.; Decision and Order
Frequently asked questions
What does Aforeworn monitor for Pharmacy & Controlled Substances?
Aforeworn continuously tracks the official rules, ordinances, fee schedules and licensing requirements that affect Pharmacy & Controlled Substances, detects every change, and explains in plain English what changed, who it hits and what to do.
How fast will I hear about a change in Pharmacy & Controlled Substances?
Changes are detected automatically as sources update, and subscribers are alerted in real time — often before the change is widely reported.
Why does staying current on Pharmacy & Controlled Substances matter?
A single missed change can mean fines, a lapsed licence, or lost eligibility. Forewarned is forearmed — knowing first lets you act before it costs you.